These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
135 related articles for article (PubMed ID: 15537355)
41. Ligands to the (IRAP)/AT4 receptor encompassing a 4-hydroxydiphenylmethane scaffold replacing Tyr2. Andersson H; Demaegdt H; Vauquelin G; Lindeberg G; Karlén A; Hallberg M Bioorg Med Chem; 2008 Jul; 16(14):6924-35. PubMed ID: 18556208 [TBL] [Abstract][Full Text] [Related]
42. Synthesis of angiotensin II analogues by incorporating beta-homotyrosine or beta-homoisoleucine residues. Stachowiak K; Khosla MC; Plucinska K; Khairallah PA; Bumpus FM J Med Chem; 1979 Sep; 22(9):1128-30. PubMed ID: 490561 [TBL] [Abstract][Full Text] [Related]
43. Variety of angiotensin receptors in 3T3-L1 preadipose cells and differentiated adipocytes. Weiland F; Verspohl EJ Horm Metab Res; 2008 Nov; 40(11):760-6. PubMed ID: 18711690 [TBL] [Abstract][Full Text] [Related]
44. Beta-homo-amino acid scan of angiotensin IV. Lukaszuk A; Demaegdt H; Szemenyei E; Tóth G; Tymecka D; Misicka A; Karoyan P; Vanderheyden P; Vauquelin G; Tourwé D J Med Chem; 2008 Apr; 51(7):2291-6. PubMed ID: 18386881 [TBL] [Abstract][Full Text] [Related]
45. Angiotensin II analogues with sulphur-containing side-chains in position 5. A structure-activity relationship study. Pérodin J; Bouley R; Escher E; Assimomytis N; Magafa V; Manessi-Zoupa E; Theodoropoulos D; Cordopatis P Arzneimittelforschung; 2000 Jun; 50(6):526-9. PubMed ID: 10918944 [TBL] [Abstract][Full Text] [Related]
46. Photoaffinity labeling of the angiotensin II receptor. 1. Synthesis and biological activities of the labeling peptides. Escher EH; Nguyen TM; Robert H; St-Pierre SA; Regoli DC J Med Chem; 1978 Sep; 21(9):860-4. PubMed ID: 214562 [TBL] [Abstract][Full Text] [Related]
47. Role of the NH2-terminal domain of angiotensin II (ANG II) and [Sar1]angiotensin II on conformation and activity. NMR evidence for aromatic ring clustering and peptide backbone folding compared with [des-1,2,3]angiotensin II. Matsoukas JM; Hondrelis J; Keramida M; Mavromoustakos T; Makriyannis A; Yamdagni R; Wu Q; Moore GJ J Biol Chem; 1994 Feb; 269(7):5303-12. PubMed ID: 8106515 [TBL] [Abstract][Full Text] [Related]
48. Combined angiotensin II type 1 and type 2 receptor blockade on vascular remodeling and matrix metalloproteinases in resistance arteries. Brassard P; Amiri F; Schiffrin EL Hypertension; 2005 Sep; 46(3):598-606. PubMed ID: 16043661 [TBL] [Abstract][Full Text] [Related]
49. Design, synthesis, and application of azabicyclo[X.Y.0]alkanone amino acids as constrained dipeptide surrogates and peptide mimics. Cluzeau J; Lubell WD Biopolymers; 2005; 80(2-3):98-150. PubMed ID: 15795926 [TBL] [Abstract][Full Text] [Related]
50. Role of Phe308 in the seventh transmembrane domain of the AT2 receptor in ligand binding and signaling. Pulakat L; Mandavia CH; Gavini N Biochem Biophys Res Commun; 2004 Jul; 319(4):1138-43. PubMed ID: 15194486 [TBL] [Abstract][Full Text] [Related]
51. Pharmacophore, drug metabolism, and pharmacokinetics models on non-peptide AT1, AT2, and AT1/AT2 angiotensin II receptor antagonists. Berellini G; Cruciani G; Mannhold R J Med Chem; 2005 Jun; 48(13):4389-99. PubMed ID: 15974591 [TBL] [Abstract][Full Text] [Related]
52. Angiotensin II and angiotensin-(1-7) inhibit the inner cortex Na+ -ATPase activity through AT2 receptor. De Souza AM; Lopes AG; Pizzino CP; Fossari RN; Miguel NC; Cardozo FP; Abi-Abib R; Fernandes MS; Santos DP; Caruso-Neves C Regul Pept; 2004 Aug; 120(1-3):167-75. PubMed ID: 15177935 [TBL] [Abstract][Full Text] [Related]
54. Design, synthesis, and conformational analysis of azacycloalkane amino acids as conformationally constrained probes for mimicry of peptide secondary structures. Halab L; Gosselin F; Lubell WD Biopolymers; 2000; 55(2):101-22. PubMed ID: 11074409 [TBL] [Abstract][Full Text] [Related]
55. Effect of tyrosine ionization upon biological activities of angiotensin II and two new peptide analogues. Nakaie CR; Oshiro ME; Goissis G; Paiva AC Biochim Biophys Acta; 1977 Nov; 495(1):151-8. PubMed ID: 20979 [TBL] [Abstract][Full Text] [Related]
56. Synthesis and antiviral activity of the carbocyclic analogue of the highly potent and selective anti-VZV bicyclo furano pyrimidines. Migliore MD; Zonta N; McGuigan C; Henson G; Andrei G; Snoeck R; Balzarini J J Med Chem; 2007 Dec; 50(26):6485-92. PubMed ID: 18052321 [TBL] [Abstract][Full Text] [Related]
57. Novel synthesis of cyclic amide-linked analogues of angiotensins II and III. Matsoukas JM; Hondrelis J; Agelis G; Barlos K; Gatos D; Ganter R; Moore D; Moore GJ J Med Chem; 1994 Sep; 37(18):2958-69. PubMed ID: 8071943 [TBL] [Abstract][Full Text] [Related]
58. Role of the His273 located in the sixth transmembrane domain of the angiotensin II receptor subtype AT2 in ligand-receptor interaction. Turner CA; Cooper S; Pulakat L Biochem Biophys Res Commun; 1999 Apr; 257(3):704-7. PubMed ID: 10208847 [TBL] [Abstract][Full Text] [Related]
59. Angiotensin II-induced neural differentiation via angiotensin II type 2 (AT2) receptor-MMS2 cascade involving interaction between AT2 receptor-interacting protein and Src homology 2 domain-containing protein-tyrosine phosphatase 1. Li JM; Mogi M; Tsukuda K; Tomochika H; Iwanami J; Min LJ; Nahmias C; Iwai M; Horiuchi M Mol Endocrinol; 2007 Feb; 21(2):499-511. PubMed ID: 17068200 [TBL] [Abstract][Full Text] [Related]
60. Coexpression of AT1 and AT2 receptors by human fibroblasts is associated with resistance to angiotensin II. Galindo M; Santiago B; Palao G; Gutierrez-Cañas I; Ramirez JC; Pablos JL Peptides; 2005 Sep; 26(9):1647-53. PubMed ID: 16112405 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]